Health ❯ Cardiovascular Health ❯ Cardiovascular Disease
Hypertension Mortality Gender Differences Prevention Strategies Young Adults Biomarkers Kidney Disease Mortality Rates Self-Employment Obesity Step Patterns MRI Scans Women and Heart Disease COVID-19 Association Dietary Management Dietary Impact Heart Disease Heart Attacks Statins Heart Attack Management Strategies Immigrant Health Birthweight Chronotype Relationship Impact Inflammation Lifestyle Interventions Sleep Patterns Screening Guidelines MACE
Want to see what podcasts are saying about this topic? Search across 145K+ podcasts. Explore Radar
The agency cleared the label on Aug. 28, 2026 after Lilly’s head‑to‑head SURPASS‑CVOT showed a modest cardiovascular advantage over Trulicity, a result that broadens Mounjaro’s clinical and commercial role.
